 01 Certain infectious or parasitic diseases
|
|
02 Neoplasms
|
|
 03 Diseases of the blood or blood-forming organs
|
Anaemias or other erythrocyte disorders
|
Nutritional or metabolic anaemias
|
Haemolytic anaemias
|
Congenital haemolytic anaemia
|
3A10 Hereditary haemolytic anaemia
|
3A10.0 Haemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies
|
 3A10.00 Haemolytic anaemia due to glucose-6-phosphate dehydrogenase deficiency
3A10.0Y Other specified haemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies
3A10.0Z Haemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies, unspecified
|
3A10.1 Haemolytic anaemia due to adenosine deaminase excess
|
3A10.2 Hereditary elliptocytosis
|
3A10.3 Familial pseudohyperkalaemia
|
3A10.Y Other specified hereditary haemolytic anaemia
|
3A10.Z Hereditary haemolytic anaemia, unspecified
|
3A1Y Other specified congenital haemolytic anaemia
|
Acquired haemolytic anaemia
|
3A4Z Haemolytic anaemias, unspecified
|
3A50 Thalassaemias
|
3A51 Sickle cell disorders or other haemoglobinopathies
|
Pure red cell aplasia
|
3A70 Aplastic anaemia
|
3A71 Anaemia due to chronic disease
|
3A72 Sideroblastic anaemia
|
3A73 Congenital dyserythropoietic anaemia
|
Polycythaemia
|
3A90 Anaemia due to acute disease
|
3A91 Congenital methaemoglobinaemia
|
3A92 Hereditary methaemoglobinaemia
|
3A93 Acquired methaemoglobinaemia
|
3A94 Acute posthaemorrhagic anaemia
|
3A9Y Other specified anaemias or erythrocyte disorders
|
3A9Z Anaemias or other erythrocyte disorders, unspecified
|
Coagulation defects, purpura or other haemorrhagic or related conditions
|
Diseases of spleen
|
3C0Y Other specified diseases of the blood or blood-forming organs
|
3C0Z Diseases of the blood or blood-forming organs, unspecified
|
|
04 Diseases of the immune system
|
Primary immunodeficiencies
|
4A20 Acquired immunodeficiencies
|
Nonorgan specific systemic autoimmune disorders
|
Autoinflammatory disorders
|
Allergic or hypersensitivity conditions
|
Immune system disorders involving white cell lineages
|
4B00 Disorders of neutrophil number
|
4B01 Disorders of neutrophil function
|
4B01.0 Constitutional disorders of neutrophil function
|
4B01.00 Disorders of neutrophil adhesion
4B01.01 Disorders of neutrophil chemotaxis
4B01.02 Disorders of neutrophil granule formation or release
4B01.03 Disorders of neutrophil oxidative metabolism
4B01.0Y Other specified constitutional disorders of neutrophil function
4B01.0Z Constitutional disorders of neutrophil function, unspecified
|
4B01.1 Acquired disorders of neutrophil function
|
4B01.Z Disorders of neutrophil function, unspecified
|
4B02 Eosinopenia
|
4B03 Eosinophilia
|
4B04 Disorders with decreased monocyte counts
|
4B05 Disorders with increased monocyte counts
|
4B06 Acquired lymphopenia
|
4B07 Acquired lymphocytosis
|
4B0Y Other specified immune system disorders involving white cell lineages
|
4B0Z Immune system disorders involving white cell lineages, unspecified
|
Certain disorders involving the immune system
|
4B40 Diseases of thymus
|
4B4Y Other specified diseases of the immune system
|
4B4Z Diseases of the immune system, unspecified
|
|
05 Endocrine, nutritional or metabolic diseases
|
Endocrine diseases
|
Nutritional disorders
|
Metabolic disorders
|
Inborn errors of metabolism
|
5C50 Inborn errors of amino acid or other organic acid metabolism
|
5C50.0 Phenylketonuria
|
5C50.1 Disorders of tyrosine metabolism
|
5C50.10 Alkaptonuria
5C50.11 Tyrosinaemia type 1
5C50.12 Tyrosinaemia type 2
5C50.1Y Other specified disorders of tyrosine metabolism
5C50.1Z Disorders of tyrosine metabolism, unspecified
|
5C50.2 Disorders of histidine metabolism
|
5C50.20 Histidinaemia
5C50.21 Urocanic aciduria
5C50.2Y Other specified disorders of histidine metabolism
5C50.2Z Disorders of histidine metabolism, unspecified
|
5C50.3 Disorders of tryptophan metabolism
|
5C50.4 Disorders of lysine or hydroxylysine metabolism
|
5C50.5 Disorders of the gamma-glutamyl cycle
|
5C50.6 Disorders of serine metabolism
|
5C50.7 Disorders of glycine metabolism
|
5C50.70 Glycine encephalopathy
5C50.71 Sarcosinaemia
5C50.7Y Other specified disorders of glycine metabolism
5C50.7Z Disorders of glycine metabolism, unspecified
|
5C50.8 Disorders of proline or hydroxyproline metabolism
|
5C50.9 Disorders of ornithine metabolism
|
5C50.A Disorders of urea cycle metabolism
|
5C50.A0 Argininosuccinic aciduria
5C50.A1 Carbamoylphosphate synthetase deficiency
5C50.A2 Argininaemia
5C50.A3 Citrullinaemia
5C50.AY Other specified disorders of urea cycle metabolism
5C50.AZ Disorders of urea cycle metabolism, unspecified
|
5C50.B Disorders of methionine cycle or sulphur amino acid metabolism
|
5C50.C Disorders of beta or omega amino acid metabolism
|
5C50.D Disorders of branched-chain amino acid metabolism
|
5C50.D0 Maple-syrup-urine disease
5C50.DY Other specified disorders of branched-chain amino acid metabolism
5C50.DZ Disorders of branched-chain amino acid metabolism, unspecified
|
5C50.E Organic aciduria
|
5C50.F Disorders of peptide metabolism
|
5C50.F0 Prolidase deficiency
5C50.F1 Carnosinaemia
5C50.F2 Homocarnosinosis
5C50.FY Other specified disorders of peptide metabolism
5C50.FZ Disorders of peptide metabolism, unspecified
|
5C50.G Trimethylaminuria
|
5C50.Y Other specified inborn errors of amino acid or other organic acid metabolism
|
5C50.Z Inborn errors of amino acid or other organic acid metabolism, unspecified
|
5C51 Inborn errors of carbohydrate metabolism
|
5C51.0 Disorders of the pentose phosphate pathway
|
5C51.1 Disorders of glycerol metabolism
|
5C51.2 Disorders of glyoxylate metabolism
|
5C51.20 Primary hyperoxaluria type 1
5C51.2Y Other specified disorders of glyoxylate metabolism
5C51.2Z Disorders of glyoxylate metabolism, unspecified
|
5C51.3 Glycogen storage disease
|
5C51.4 Disorders of galactose metabolism
|
5C51.40 Galactose-1-phosphate uridyltransferase deficiency
5C51.41 Galactokinase deficiency
5C51.42 Glucose or galactose intolerance of newborn
5C51.4Y Other specified disorders of galactose metabolism
5C51.4Z Disorders of galactose metabolism, unspecified
|
5C51.5 Disorders of fructose metabolism
|
5C51.50 Hereditary fructose intolerance
5C51.5Y Other specified disorders of fructose metabolism
5C51.5Z Disorders of fructose metabolism, unspecified
|
5C51.Y Other specified inborn errors of carbohydrate metabolism
|
5C51.Z Inborn errors of carbohydrate metabolism, unspecified
|
5C52 Inborn errors of lipid metabolism
|
5C52.0 Inborn errors of fatty acid oxidation or ketone body metabolism
|
5C52.00 Disorders of carnitine transport or the carnitine cycle
5C52.01 Disorders of mitochondrial fatty acid oxidation
5C52.02 Disorders of ketone body metabolism
5C52.03 Sjögren-Larsson syndrome
5C52.0Y Other specified inborn errors of fatty acid oxidation or ketone body metabolism
5C52.0Z Inborn errors of fatty acid oxidation or ketone body metabolism, unspecified
|
5C52.1 Inborn errors of sterol metabolism
|
5C52.10 Disorders of cholesterol synthesis
5C52.11 Bile acid synthesis defect with cholestasis
5C52.1Y Other specified inborn errors of sterol metabolism
5C52.1Z Inborn errors of sterol metabolism, unspecified
|
5C52.2 Neutral lipid storage disease
|
5C52.Y Other specified inborn errors of lipid metabolism
|
5C52.Z Inborn errors of lipid metabolism, unspecified
|
5C53 Inborn errors of energy metabolism
|
5C53.0 Disorders of pyruvate metabolism
|
5C53.00 Pyruvate kinase deficiency
5C53.01 Lactate dehydrogenase deficiency
5C53.02 Pyruvate dehydrogenase complex deficiency
5C53.03 Pyruvate carboxylase deficiency
5C53.0Y Other specified disorders of pyruvate metabolism
5C53.0Z Disorders of pyruvate metabolism, unspecified
|
5C53.1 Disorders of the citric acid cycle
|
5C53.2 Disorders of mitochondrial oxidative phosphorylation
|
5C53.3 Disorders of mitochondrial membrane transport
|
5C53.4 Disorders of creatine metabolism
|
5C53.Y Other specified inborn errors of energy metabolism
|
5C53.Z Inborn errors of energy metabolism, unspecified
|
5C54 Inborn errors of glycosylation or other specified protein modification
|
5C55 Inborn errors of purine, pyrimidine or nucleotide metabolism
|
5C55.0 Disorders of purine metabolism
|
5C55.00 Xanthinuria
5C55.01 Lesch-Nyhan syndrome
5C55.0Y Other specified disorders of purine metabolism
5C55.0Z Disorders of purine metabolism, unspecified
|
5C55.1 Disorders of pyrimidine metabolism
|
5C55.2 Disorders of nucleotide metabolism
|
5C55.Y Other specified inborn errors of purine, pyrimidine or nucleotide metabolism
|
5C55.Z Inborn errors of purine, pyrimidine or nucleotide metabolism, unspecified
|
5C56 Lysosomal diseases
|
5C56.0 Sphingolipidosis
|
5C56.1 Neuronal ceroid lipofuscinosis
|
5C56.2 Glycoproteinosis
|
5C56.3 Mucopolysaccharidosis
|
5C56.4 Disorders of sialic acid metabolism
|
5C56.Y Other specified lysosomal diseases
|
5C56.Z Lysosomal diseases, unspecified
|
5C57 Peroxisomal diseases
|
5C58 Inborn errors of porphyrin or heme metabolism
|
5C58.0 Disorders of bilirubin metabolism or excretion
|
5C58.00 Crigler-Najjar syndrome
5C58.01 Gilbert syndrome
5C58.02 Dubin-Johnson syndrome
5C58.03 Progressive familial intrahepatic cholestasis
5C58.04 Benign recurrent intrahepatic cholestasis
5C58.0Y Other specified disorders of bilirubin metabolism or excretion
5C58.0Z Disorders of bilirubin metabolism or excretion, unspecified
|
5C58.1 Porphyrias
|
5C58.Y Other specified inborn errors of porphyrin or heme metabolism
|
5C58.Z Inborn errors of porphyrin or heme metabolism, unspecified
|
5C59 Inborn errors of neurotransmitter metabolism
|
5C59.0 Disorders of biogenic amine metabolism
|
5C59.00 Disorders of catecholamine synthesis
5C59.01 Disorders of pterin metabolism
5C59.0Y Other specified disorders of biogenic amine metabolism
5C59.0Z Disorders of biogenic amine metabolism, unspecified
|
5C59.1 Disorders of gamma aminobutyric acid metabolism
|
5C59.2 Disorders of pyridoxine metabolism
|
5C59.Y Other specified inborn errors of neurotransmitter metabolism
|
5C59.Z Inborn errors of neurotransmitter metabolism, unspecified
|
5C5A Alpha-1-antitrypsin deficiency
|
5C5Y Other specified inborn errors of metabolism
|
5C5Z Inborn errors of metabolism, unspecified
|
Disorders of metabolite absorption or transport
|
5C60 Disorders of amino acid absorption or transport
|
5C61 Disorders of carbohydrate absorption or transport
|
5C62 Disorders of lipid absorption or transport
|
5C63 Disorders of vitamin or non-protein cofactor absorption or transport
|
5C63.0 Disorders of cobalamin metabolism or transport
|
5C63.1 Disorders of folate metabolism or transport
|
5C63.2 Disorders of vitamin D metabolism or transport
|
5C63.20 Hypocalcaemic vitamin D dependent rickets
5C63.21 Hypocalcaemic vitamin D resistant rickets
5C63.22 Hypophosphataemic rickets
5C63.2Y Other specified disorders of vitamin D metabolism or transport
5C63.2Z Disorders of vitamin D metabolism or transport, unspecified
|
5C63.Y Other specified disorders of vitamin or non-protein cofactor absorption or transport
|
5C63.Z Disorders of vitamin or non-protein cofactor absorption or transport, unspecified
|
5C64 Disorders of mineral absorption or transport
|
5C64.0 Disorders of copper metabolism
|
5C64.00 Wilson disease
5C64.0Y Other specified disorders of copper metabolism
5C64.0Z Disorders of copper metabolism, unspecified
|
5C64.1 Disorders of iron metabolism
|
5C64.10 Iron overload diseases
5C64.1Y Other specified disorders of iron metabolism
5C64.1Z Disorders of iron metabolism, unspecified
|
5C64.2 Disorders of zinc metabolism
|
5C64.20 Acrodermatitis enteropathica
5C64.21 Zinc deficiency syndromes
5C64.2Y Other specified disorders of zinc metabolism
5C64.2Z Disorders of zinc metabolism, unspecified
|
5C64.3 Disorders of phosphorus metabolism or phosphatases
|
5C64.4 Disorders of magnesium metabolism
|
5C64.40 Hypermagnesaemia
5C64.41 Hypomagnesaemia
5C64.4Z Disorders of magnesium metabolism, unspecified
|
5C64.5 Disorders of calcium metabolism
|
5C64.6 Disorders of sodium metabolism
|
5C64.7 Disorders of chloride metabolism
|
5C64.Y Disorders of other specified mineral absorption and transport
|
5C64.Z Disorders of mineral absorption or transport, unspecified
|
5C6Y Other specified disorders of metabolite absorption or transport
|
5C6Z Disorders of metabolite absorption or transport, unspecified
|
Disorders of fluid, electrolyte or acid-base balance
|
Disorders of lipoprotein metabolism or certain specified lipidaemias
|
5C80 Hyperlipoproteinaemia
|
5C81 Hypolipoproteinaemia
|
5C8Y Other specified disorders of lipoprotein metabolism or lipidaemias
|
5C8Z Unspecified disorders of lipoprotein metabolism or lipidaemias
|
5C90 Metabolic or transporter liver disease
|
5C90.0 Liver diseases due to urea cycle defects
5C90.1 Liver diseases due to disorders of porphyrin or bilirubin metabolism or transport
5C90.2 Liver diseases due to disorders of amino acid metabolism
5C90.3 Liver disease due to disorders of lysosomal storage
5C90.4 Liver diseases due to mitochondrial disorders
5C90.5 Liver diseases due to disorders of mineral metabolism
5C90.Y Other specified metabolic or transporter liver disease
5C90.Z Metabolic or transporter liver disease, unspecified
|
Other metabolic disorders
|
5D2Z Metabolic disorders, unspecified
|
Postprocedural endocrine or metabolic disorders
|
|
06 Mental, behavioural or neurodevelopmental disorders
|
|
07 Sleep-wake disorders
|
|
08 Diseases of the nervous system
|
|
09 Diseases of the visual system
|
|
10 Diseases of the ear or mastoid process
|
|
11 Diseases of the circulatory system
|
|
12 Diseases of the respiratory system
|
Upper respiratory tract disorders
|
Certain lower respiratory tract diseases
|
Lung infections
|
Lung diseases due to external agents
|
Respiratory diseases principally affecting the lung interstitium
|
CB00 Acute respiratory distress syndrome
|
CB01 Pulmonary oedema
|
CB02 Pulmonary eosinophilia
|
CB03 Idiopathic interstitial pneumonitis
|
CB04 Primary interstitial lung diseases specific to infancy or childhood
|
CB04.0 Diffuse pulmonary developmental disorders
|
CB04.1 Pulmonary lymphatic dysplasia syndromes
|
CB04.2 Disorders of surfactant metabolism
|
CB04.3 Alveolar or peri-alveolar conditions
|
CB04.4 Pulmonary capillaritis
|
CB04.5 Brain-lung-thyroid syndrome
|
CB04.6 Chronic pneumonitis of infancy
|
CB04.7 Neuroendocrine cell hyperplasia of infancy
|
CB04.Y Other specified primary interstitial lung diseases specific to infancy or childhood
|
CB04.Z Primary interstitial lung diseases specific to infancy or childhood, unspecified
|
CB05 Interstitial lung diseases associated with systemic diseases
|
CB06 Pulmonary alveolar microlithiasis
|
CB07 Lymphangioleiomyomatosis
|
CB0Y Other specified respiratory diseases principally affecting the lung interstitium
|
CB0Z Respiratory diseases principally affecting the lung interstitium, unspecified
|
Pleural, diaphragm or mediastinal disorders
|
CB40 Certain diseases of the respiratory system
|
CB41 Respiratory failure
|
Postprocedural disorders of the respiratory system
|
CB7Z Diseases of the respiratory system, unspecified
|
|
13 Diseases of the digestive system
|
|
14 Diseases of the skin
|
Certain skin disorders attributable to infection or infestation
|
Inflammatory dermatoses
|
Metabolic and nutritional disorders affecting the skin
|
EB90 Dermatoses resulting from disturbed metabolic processes
|
EB90.0 Diabetic skin lesions
|
EB90.1 Cutaneous mucinosis
|
EB90.2 Cutaneous and subcutaneous xanthomata
|
EB90.20 Plane xanthoma
EB90.21 Tuberous xanthoma
EB90.22 Eruptive xanthoma
EB90.23 Tendinous xanthoma
EB90.24 Xanthoma due to specified disorder of lipid metabolism
EB90.2Z Cutaneous and subcutaneous xanthomata of unspecified type
|
EB90.3 Porphyria or pseudoporphyria affecting the skin
|
EB90.4 Calcification of skin or subcutaneous tissue
|
EB9Y Other specified metabolic and nutritional disorders affecting the skin
|
Genetic and developmental disorders affecting the skin
|
Sensory and psychological disorders affecting the skin
|
Skin disorders involving specific cutaneous structures
|
Skin disorders involving certain specific body regions
|
Skin disorders associated with pregnancy, the neonatal period and infancy
|
Adverse cutaneous reactions to medication
|
Skin disorders provoked by external factors
|
Benign proliferations, neoplasms and cysts of the skin
|
Disorders of the skin of uncertain or unpredictable malignant potential
|
Cutaneous markers of internal disorders
|
Postprocedural disorders of the skin
|
EM0Y Other specified diseases of the skin
|
EM0Z Skin disease of unspecified nature
|
|
15 Diseases of the musculoskeletal system or connective tissue
|
|
16 Diseases of the genitourinary system
|
|
17 Conditions related to sexual health
|
|
18 Pregnancy, childbirth or the puerperium
|
|
19 Certain conditions originating in the perinatal period
|
Fetus or newborn affected by maternal factors or by complications of pregnancy, labour or delivery
|
Disorders of newborn related to length of gestation or fetal growth
|
Birth injury
|
Infections of the fetus or newborn
|
Haemorrhagic or haematological disorders of fetus or newborn
|
Neurological disorders specific to the perinatal or neonatal period
|
Respiratory disorders specific to the perinatal or neonatal period
|
Cardiovascular disorders present in the perinatal or neonatal period
|
Transitory endocrine or metabolic disorders specific to fetus or newborn
|
KB60 Transitory disorders of carbohydrate metabolism specific to fetus or newborn
|
KB60.0 Syndrome of infant of mother with gestational diabetes
|
KB60.1 Syndrome of infant of a diabetic mother, type 1 or 2, nongestational, insulin dependent
|
KB60.2 Neonatal diabetes mellitus
|
KB60.3 Neonatal hyperglycaemia
|
KB60.4 Neonatal hypoglycaemia
|
KB60.Y Other specified transitory disorders of carbohydrate metabolism specific to fetus or newborn
|
KB60.Z Transitory disorders of carbohydrate metabolism specific to fetus or newborn, unspecified
|
KB61 Transitory neonatal disorders of calcium or magnesium metabolism
|
KB61.0 Neonatal hypomagnesaemia
KB61.1 Neonatal tetany without calcium or magnesium deficiency
KB61.2 Neonatal hypocalcaemia
KB61.3 Neonatal osteopenia
KB61.Y Other specified transitory neonatal disorders of calcium or magnesium metabolism
KB61.Z Transitory neonatal disorders of calcium or magnesium metabolism, unspecified
|
KB62 Transitory neonatal disorders of thyroid function
|
KB63 Certain specified transitory neonatal electrolyte or metabolic disturbances
|
KB64 Transitory neonatal hypoparathyroidism
|
KB6Z Transitory endocrine or metabolic disorders specific to fetus or newborn, unspecified
|
Digestive system disorders of fetus or newborn
|
Genitourinary system disorders specific to the perinatal or neonatal period
|
Disorders involving the integument of fetus or newborn
|
Disturbances of temperature regulation of newborn
|
Certain disorders originating in the perinatal period
|
KD5Z Conditions originating in the perinatal or neonatal period, unspecified
|
|
20 Developmental anomalies
|
Structural developmental anomalies primarily affecting one body system
|
Multiple developmental anomalies or syndromes
|
LD20 Syndromes with central nervous system anomalies as a major feature
|
LD21 Syndromes with eye anomalies as a major feature
|
LD22 Syndromes with dental anomalies as a major feature
|
LD23 Syndromes with vascular anomalies as a major feature
|
LD24 Syndromes with skeletal anomalies as a major feature
|
LD25 Syndromes with face or limb anomalies as a major feature
|
LD26 Syndromes with limb anomalies as a major feature
|
LD27 Syndromes with skin or mucosal anomalies as a major feature
|
LD28 Syndromes with connective tissue involvement as a major feature
|
LD29 Syndromes with obesity as a major feature
|
LD2A Malformative disorders of sex development
|
LD2A.0 Ovotesticular disorder of sex development
LD2A.1 46,XY gonadal dysgenesis
LD2A.2 Testicular agenesis
LD2A.3 46,XY disorder of sex development due to a defect in testosterone metabolism
LD2A.4 46,XY disorder of sex development due to androgen resistance
LD2A.Y Other specified malformative disorders of sex development
LD2A.Z Malformative disorders of sex development, unspecified
|
LD2B Syndromes with premature ageing appearance as a major feature
|
LD2C Overgrowth syndromes
|
LD2D Phakomatoses or hamartoneoplastic syndromes
|
LD2E Syndromes with structural anomalies due to inborn errors of metabolism
|
LD2F Syndromes with multiple structural anomalies, without predominant body system involvement
|
LD2G Conjoined twins
|
LD2H Syndromic genetic deafness
|
LD2Y Other specified multiple developmental anomalies or syndromes
|
LD2Z Multiple developmental anomalies or syndromes, unspecified
|
Chromosomal anomalies, excluding gene mutations
|
LD90 Conditions with disorders of intellectual development as a relevant clinical feature
|
LD9Y Other specified developmental anomalies
|
LD9Z Developmental anomalies, unspecified
|
|
21 Symptoms, signs or clinical findings, not elsewhere classified
|
|
22 Injury, poisoning or certain other consequences of external causes
|
|
23 External causes of morbidity or mortality
|
|
24 Factors influencing health status or contact with health services
|
|
25 Codes for special purposes
|
|
26 Supplementary Chapter Traditional Medicine Conditions
|
|
27 Supplementary section for functioning assessment
|
ICD-11 International Classification of Diseases